The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Raykov Rosty | Insider | Sell(S) | 10K | $9.58 | $96K |
| Jul 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| Jul 31, 2026 | Raykov Rosty | Insider | Grant(A) | 3K | — | $0 |
| Jul 31, 2026 | Evans Terry L | Chief Commercial Officer | Grant(A) | 168 | — | $0 |
| Jul 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Grant(A) | 1K | — | $0 |
| Jul 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Grant(A) | 156 | — | $0 |
| Jul 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Grant(A) | 168 | — | $0 |
| Jul 1, 2026 | Raykov Rosty | Insider | Grant(A) | 3K | — | $0 |
| Jul 1, 2026 | Raykov Rosty | Insider | Option exercise(M) | 16K | $2.45 | $38K |
| Jul 1, 2026 | Raykov Rosty | Insider | Sell(S) | 10K | $10.41 | $100K |
| Jul 1, 2026 | Raykov Rosty | Insider | Option exercise(M) | 16K | $2.45 | $38K |
| Jun 30, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| Jun 30, 2026 | Evans Terry L | Chief Commercial Officer | Grant(A) | 168 | — | $0 |
| Jun 30, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Grant(A) | 156 | — | $0 |
| Jun 30, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Grant(A) | 1K | — | $0 |
| Jun 30, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Grant(A) | 168 | — | $0 |
| Jun 10, 2026 | Islam Khalid | Director | Grant(A) | 25K | $8.70 | $218K |
| Jun 10, 2026 | Rallis Chris A | Director | Grant(A) | 20K | $8.70 | $174K |
| Jun 10, 2026 | Brughera Marco Maria | Director | Grant(A) | 20K | $8.70 | $174K |
| Jun 10, 2026 | Cook Jodi A | Director | Grant(A) | 20K | $8.70 | $174K |
| Jun 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Jun 1, 2026 | Raykov Rosty | Director | Sell(S) | 10K | $9.62 | $94K |
| Jun 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| May 31, 2026 | Raykov Rosty | Director | Grant(A) | 3K | — | $0 |
| May 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Grant(A) | 168 | — | $0 |
| May 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Grant(A) | 1K | — | $0 |
| May 31, 2026 | Evans Terry L | Chief Commercial Officer | Grant(A) | 168 | — | $0 |
| May 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Grant(A) | 156 | — | $0 |
| May 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| May 11, 2026 | Rallis Chris A | Director | Option exercise(M) | 14K | $2.44 | $35K |
| May 11, 2026 | Rallis Chris A | Director | Sell(S) | 8K | $7.04 | $59K |
| May 11, 2026 | Rallis Chris A | Director | Option exercise(M) | 14K | $2.44 | $35K |
| May 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| May 1, 2026 | Raykov Rosty | Director | Sell(S) | 11K | $6.47 | $70K |
| May 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Apr 30, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Option exercise(M) | 168 | — | $0 |
| Apr 30, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Option exercise(M) | 1K | — | $0 |
| Apr 30, 2026 | Raykov Rosty | Director | Option exercise(M) | 3K | — | $0 |
| Apr 30, 2026 | Evans Terry L | Chief Commercial Officer | Option exercise(M) | 168 | — | $0 |
| Apr 30, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 155 | — | $0 |
| Apr 30, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Apr 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Apr 1, 2026 | Raykov Rosty | Director | Sell(S) | 11K | $6.31 | $69K |
| Apr 1, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Mar 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Grant(A) | 120K | $5.77 | $692K |
| Mar 31, 2026 | Raykov Rosty | Director | Grant(A) | 5K | — | $0 |
| Mar 31, 2026 | Evans Terry L | Chief Commercial Officer | Grant(A) | 120K | $5.77 | $692K |
| Mar 31, 2026 | Evans Terry L | Chief Commercial Officer | Option exercise(M) | 171 | — | $0 |
| Mar 31, 2026 | Evans Terry L | Chief Commercial Officer | Option exercise(M) | 18K | — | $0 |
| Mar 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 15K | — | $0 |
| Mar 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | — | $0 |
| Mar 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 120K | $5.77 | $692K |
| Mar 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 17K | — | $0 |
| Mar 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 158 | — | $0 |
| Mar 31, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Grant(A) | 120K | $5.77 | $692K |
| Mar 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Option exercise(M) | 17K | — | $0 |
| Mar 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Option exercise(M) | 1K | — | $0 |
| Mar 31, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Grant(A) | 200K | $5.77 | $1.2M |
| Mar 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Option exercise(M) | 171 | — | $0 |
| Mar 31, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Option exercise(M) | 18K | — | $0 |
| Mar 28, 2026 | Sayad Pierre Sargis | Chief Medical Officer | Option exercise(M) | 2K | — | $0 |
| Mar 28, 2026 | Evans Terry L | Chief Commercial Officer | Option exercise(M) | 2K | — | $0 |
| Mar 28, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 12K | — | $0 |
| Mar 28, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 2K | — | $0 |
| Mar 28, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Mar 26, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 13K | $5.10 | $67K |
| Mar 26, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 13K | $5.10 | $67K |
| Mar 26, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 5K | $4.23 | $20K |
| Mar 26, 2026 | Cioffi Christiana Marie | Chief Strategy Officer | Option exercise(M) | 5K | $4.23 | $20K |
| Mar 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Mar 2, 2026 | Raykov Rosty | Director | Sell(S) | 10K | $8.36 | $84K |
| Mar 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Feb 28, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 1K | — | $0 |
| Feb 28, 2026 | Raykov Rosty | Director | Grant(A) | 5K | — | $0 |
| Feb 18, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 27K | — | $0 |
| Feb 18, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | $4.08 | $10K |
| Feb 18, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 2K | $4.08 | $10K |
| Feb 18, 2026 | Hackman Jeffrey S. | Chief Executive Officer, Director | Option exercise(M) | 14K | — | $0 |
| Feb 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Feb 2, 2026 | Raykov Rosty | Director | Sell(S) | 10K | $7.76 | $80K |
| Feb 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Jan 31, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| Jan 31, 2026 | Raykov Rosty | Director | Grant(A) | 5K | — | $0 |
| Jan 23, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 10K | $2.45 | $25K |
| Jan 23, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 10K | $2.45 | $25K |
| Jan 15, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 10K | $2.45 | $25K |
| Jan 15, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 10K | $2.45 | $25K |
| Jan 7, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 14K | $2.45 | $35K |
| Jan 7, 2026 | Andrade Robert | CHIEF FINANCIAL OFFICER | Option exercise(M) | 14K | $2.45 | $35K |
| Jan 2, 2026 | Raykov Rosty | Director | Sell(S) | 10K | $7.60 | $78K |
| Jan 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Jan 2, 2026 | Raykov Rosty | Director | Option exercise(M) | 16K | $2.45 | $38K |
| Dec 31, 2025 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 1K | — | $0 |
| Dec 31, 2025 | Raykov Rosty | Director | Grant(A) | 5K | — | $0 |
| Dec 24, 2025 | Southpoint Capital Advisors LP | 10% Owner | Sell(S) | 1.0M | $7.50 | $7.5M |
| Dec 5, 2025 | Raykov Rosty | Director | Sell(S) | 10K | $7.54 | $75K |
| Dec 1, 2025 | Andrade Robert | CHIEF FINANCIAL OFFICER | Grant(A) | 2K | — | $0 |
| Dec 1, 2025 | Raykov Rosty | Director | Grant(A) | 5K | — | $0 |
| Nov 18, 2025 | Southpoint Capital Advisors LLC | 10% Owner | Sell(S) | 19K | $8.79 | $170K |
| Nov 17, 2025 | Southpoint GP, LLC | 10% Owner | Sell(S) | 86K | $8.79 | $755K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2019-12-30 → 2026-08-06. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for FENC